Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Supernus Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 4, 2026

$SUPNPress releaseJul 22, 2026, 5:05 PM ETRead the release

Supernus Pharmaceuticals announced it will release its second quarter 2026 financial results after the market closes on Tuesday, August 4, 2026. CEO Jack Khattar and CFO Tim Dec will host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the business and financial results.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.